Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nonalcoholic Steatohepatitis Treatment
1.2 Key Market Segments
1.2.1 Nonalcoholic Steatohepatitis Treatment Segment by Type
1.2.2 Nonalcoholic Steatohepatitis Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nonalcoholic Steatohepatitis Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nonalcoholic Steatohepatitis Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nonalcoholic Steatohepatitis Treatment Market Competitive Landscape
3.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Manufacturers (2019-2024)
3.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nonalcoholic Steatohepatitis Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nonalcoholic Steatohepatitis Treatment Sales Sites, Area Served, Product Type
3.6 Nonalcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
3.6.1 Nonalcoholic Steatohepatitis Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nonalcoholic Steatohepatitis Treatment Industry Chain Analysis
4.1 Nonalcoholic Steatohepatitis Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nonalcoholic Steatohepatitis Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nonalcoholic Steatohepatitis Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2019-2024)
6.3 Global Nonalcoholic Steatohepatitis Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Nonalcoholic Steatohepatitis Treatment Price by Type (2019-2024)
7 Nonalcoholic Steatohepatitis Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nonalcoholic Steatohepatitis Treatment Market Sales by Application (2019-2024)
7.3 Global Nonalcoholic Steatohepatitis Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Nonalcoholic Steatohepatitis Treatment Sales Growth Rate by Application (2019-2024)
8 Nonalcoholic Steatohepatitis Treatment Market Segmentation by Region
8.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Region
8.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Region
8.1.2 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Nonalcoholic Steatohepatitis Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nonalcoholic Steatohepatitis Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nonalcoholic Steatohepatitis Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca
9.1.1 AstraZeneca Nonalcoholic Steatohepatitis Treatment Basic Information
9.1.2 AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Overview
9.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Nonalcoholic Steatohepatitis Treatment SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 Arena Pharmaceuticals
9.2.1 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Basic Information
9.2.2 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Overview
9.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.2.4 Arena Pharmaceuticals Business Overview
9.2.5 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment SWOT Analysis
9.2.6 Arena Pharmaceuticals Recent Developments
9.3 GSK
9.3.1 GSK Nonalcoholic Steatohepatitis Treatment Basic Information
9.3.2 GSK Nonalcoholic Steatohepatitis Treatment Product Overview
9.3.3 GSK Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.3.4 GSK Nonalcoholic Steatohepatitis Treatment SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Basic Information
9.4.2 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Overview
9.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.4.4 Novo Nordisk Business Overview
9.4.5 Novo Nordisk Recent Developments
9.5 Roche
9.5.1 Roche Nonalcoholic Steatohepatitis Treatment Basic Information
9.5.2 Roche Nonalcoholic Steatohepatitis Treatment Product Overview
9.5.3 Roche Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Vivus
9.6.1 Vivus Nonalcoholic Steatohepatitis Treatment Basic Information
9.6.2 Vivus Nonalcoholic Steatohepatitis Treatment Product Overview
9.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.6.4 Vivus Business Overview
9.6.5 Vivus Recent Developments
9.7 Arisaph Pharmaceuticals
9.7.1 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Basic Information
9.7.2 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Overview
9.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.7.4 Arisaph Pharmaceuticals Business Overview
9.7.5 Arisaph Pharmaceuticals Recent Developments
9.8 Cempra Pharmaceuticals
9.8.1 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Basic Information
9.8.2 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Overview
9.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.8.4 Cempra Pharmaceuticals Business Overview
9.8.5 Cempra Pharmaceuticals Recent Developments
9.9 Galectin Therapeutics
9.9.1 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Basic Information
9.9.2 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Overview
9.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.9.4 Galectin Therapeutics Business Overview
9.9.5 Galectin Therapeutics Recent Developments
9.10 Galmed Pharmaceuticals
9.10.1 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Basic Information
9.10.2 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Overview
9.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.10.4 Galmed Pharmaceuticals Business Overview
9.10.5 Galmed Pharmaceuticals Recent Developments
9.11 Genfit
9.11.1 Genfit Nonalcoholic Steatohepatitis Treatment Basic Information
9.11.2 Genfit Nonalcoholic Steatohepatitis Treatment Product Overview
9.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.11.4 Genfit Business Overview
9.11.5 Genfit Recent Developments
9.12 Gilead
9.12.1 Gilead Nonalcoholic Steatohepatitis Treatment Basic Information
9.12.2 Gilead Nonalcoholic Steatohepatitis Treatment Product Overview
9.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Product Market Performance
9.12.4 Gilead Business Overview
9.12.5 Gilead Recent Developments
10 Nonalcoholic Steatohepatitis Treatment Market Forecast by Region
10.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Forecast
10.2 Global Nonalcoholic Steatohepatitis Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Region
10.2.4 South America Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nonalcoholic Steatohepatitis Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nonalcoholic Steatohepatitis Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis Treatment by Type (2025-2030)
11.1.2 Global Nonalcoholic Steatohepatitis Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nonalcoholic Steatohepatitis Treatment by Type (2025-2030)
11.2 Global Nonalcoholic Steatohepatitis Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Nonalcoholic Steatohepatitis Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings